IT-CARES: an interactive tool for case-crossover analyses of electronic medical records for patient safety
暂无分享,去创建一个
Vassilis Koutkias | Régis Beuscart | Emmanuel Chazard | Grégoire Ficheur | Laurie Ferret | Jean-Baptiste Beuscart | Renaud Perichon | Alexandre Caron | Joris Muller | R. Beuscart | E. Chazard | G. Ficheur | V. Koutkias | L. Ferret | Alexandre Caron | J. Beuscart | Renaud Perichon | J. Muller
[1] R Core Team,et al. R: A language and environment for statistical computing. , 2014 .
[2] Michelle Dunn,et al. The National Institutes of Health's Big Data to Knowledge (BD2K) initiative: capitalizing on biomedical big data , 2014, J. Am. Medical Informatics Assoc..
[3] Jesus J. Caban,et al. Visual analytics in healthcare - opportunities and research challenges , 2015, J. Am. Medical Informatics Assoc..
[4] Valerie Beral,et al. Duration and magnitude of the postoperative risk of venous thromboembolism in middle aged women: prospective cohort study , 2009, BMJ : British Medical Journal.
[5] Gordon H Guyatt,et al. Executive Summary Antithrombotic Therapy and Prevention of Thrombosis , 9 th ed : American College of Chest Physicians Evidence-Based Clinical Practice Guidelines , 2012 .
[6] M. Pagano,et al. Survival analysis. , 1996, Nutrition.
[7] James J. Thomas,et al. Challenges for Visual Analytics , 2009, Inf. Vis..
[8] Spencer S. Jones,et al. Health Information Technology: An Updated Systematic Review With a Focus on Meaningful Use , 2014, Annals of Internal Medicine.
[9] Thomas H. Payne,et al. Report of the AMIA EHR-2020 Task Force on the status and future direction of EHRs , 2015, J. Am. Medical Informatics Assoc..
[10] Rupert G. Miller,et al. Survival Analysis , 2022, The SAGE Encyclopedia of Research Design.
[11] Jarke J. van Wijk,et al. Challenges for Visual Analytics , 2017, VISIGRAPP.
[12] Carol Coupland,et al. Predicting risk of upper gastrointestinal bleed and intracranial bleed with anticoagulants: cohort study to derive and validate the QBleed scores , 2014, BMJ : British Medical Journal.
[13] P. Albaladejo,et al. Prévention de la maladie thromboembolique veineuse périopératoire et obstétricale , 2005 .
[14] J. Heit,et al. Risk factors for venous thromboembolism. , 2003, Clinics in chest medicine.
[15] S. Evans,et al. Moving Along the Yellow Brick (Card) Road? , 2013, Drug Safety.
[16] Peter Vestergaard,et al. Risk of Gastrointestinal Bleeding in Patients Undergoing Total Hip or Knee Replacement Compared With Matched Controls: A Nationwide Cohort Study , 2013, The American Journal of Gastroenterology.
[17] Jean-Luc Bosson,et al. ICD-10 hospital discharge diagnosis codes were sensitive for identifying pulmonary embolism but not deep vein thrombosis. , 2010, Journal of clinical epidemiology.
[18] Marlene R. Miller,et al. Administrative data based patient safety research: a critical review , 2003, Quality & safety in health care.
[19] Ben Shneiderman,et al. Improving Healthcare with Interactive Visualization , 2013, Computer.
[20] Thomas Wilke,et al. Nonadherence in outpatient thromboprophylaxis after major orthopedic surgery: a systematic review , 2010, Expert review of pharmacoeconomics & outcomes research.
[21] H. Wickham,et al. A Grammar of Data Manipulation , 2015 .
[22] G. Eysenbach. Infodemiology and Infoveillance: Framework for an Emerging Set of Public Health Informatics Methods to Analyze Search, Communication and Publication Behavior on the Internet , 2009, Journal of medical Internet research.
[23] Bengt I Eriksson,et al. Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial , 2008, The Lancet.
[24] C. Martin. 2015 , 2015, Les 25 ans de l’OMC: Une rétrospective en photos.
[25] S. Flanders,et al. Venous thromboembolism prophylaxis: a path toward more appropriate use , 2015, BMJ Quality & Safety.
[26] D A Kessler,et al. Introducing MEDWatch. A new approach to reporting medication and device adverse effects and product problems. , 1993, General hospital psychiatry.
[27] D. Madigan,et al. A Comparison of the Empirical Performance of Methods for a Risk Identification System , 2013, Drug Safety.
[28] G. Agnelli,et al. Insufficient duration of venous thromboembolism prophylaxis after total hip or knee replacement when compared with the time course of thromboembolic events: findings from the Global Orthopaedic Registry. , 2007, The Journal of bone and joint surgery. British volume.
[29] L. Melton,et al. Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study. , 2002, Archives of internal medicine.
[30] Colin P. West,et al. Time spent on clinical documentation: a survey of internal medicine residents and program directors. , 2010, Archives of internal medicine.
[31] Devin M Mann,et al. Efficacy of an evidence-based clinical decision support in primary care practices: a randomized clinical trial. , 2013, JAMA internal medicine.
[32] E. Schimmel. The hazards of hospitalization* , 2003 .
[33] J. Robins,et al. Control sampling strategies for case-crossover studies: an assessment of relative efficiency. , 1995, American journal of epidemiology.
[34] Richard B Devereux,et al. Risk of a thrombotic event after the 6-week postpartum period. , 2014, The New England journal of medicine.
[35] Tsung O Cheng,et al. Could elevated C-reactive protein in patients with obstructive sleep apnea be due to obesity per se? , 2003, Circulation.
[36] Patrick B. Ryan,et al. Alternative Outcome Definitions and Their Effect on the Performance of Methods for Observational Outcome Studies , 2013, Drug Safety.
[37] Hadley Wickham,et al. An Implementation of the Grammar of Graphics , 2015 .
[38] Joshua R. Vest,et al. Factors motivating and affecting health information exchange usage , 2011, J. Am. Medical Informatics Assoc..
[39] Samuel Z Goldhaber,et al. Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study , 2008, The Lancet.
[40] P. Rothwell,et al. External validity of randomised controlled trials: “To whom do the results of this trial apply?” , 2005, The Lancet.